台股 » 個股 » 旭富 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

旭富

(4119)
可現股當沖
  • 股價
    92.4
  • 漲跌
    ▲0.3
  • 漲幅
    +0.33%
  • 成交量
    176
  • 產業
    上市 生技醫療類股
  • 352人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
旭富 (4119)籌碼相關-永豐金-桃中 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-桃中 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2019/05/24292.75292.6592.0002,6920.00%
2019/05/23191.60493.3592.30-32,674-0.11%
2019/05/22796.901096.0094.50-32,646-0.11%
2019/05/211097.3000.0099.10102,6210.38%
2019/05/17596.72295.2094.9032,5650.12%
2019/05/161599.272798.90100.50-122,492-0.48%
2019/05/151198.9200.0097.30112,4210.45%
2019/05/14196.1000.0096.8012,3710.04%
2019/05/0600.001594.0091.80-152,227-0.67%
2019/05/021196.09196.2094.90102,1870.46%
2019/04/29694.08294.2092.0042,1140.19%
2019/04/261092.052090.4991.00-102,016-0.50%
2019/04/25591.4000.0090.8052,0050.25%
2019/04/24590.4000.0090.4052,0060.25%
2019/04/23290.60291.3090.9002,0020.00%
2019/04/22192.1000.0092.9011,9810.05%
2019/04/19188.90289.4089.10-11,948-0.05%
2019/04/18289.6000.0088.1021,9610.10%
2019/04/12590.00590.2090.0002,1120.00%
2019/04/11188.50391.1789.90-22,107-0.09%
2019/04/10393.1300.0092.3032,0740.14%
2019/04/09190.80290.9090.80-12,012-0.05%
2019/04/0800.00191.4091.20-12,004-0.05%
2019/04/03191.1000.0090.8011,9980.05%
2019/04/02292.45491.9891.30-21,972-0.10%
2019/04/0100.00193.5094.70-11,928-0.05%
2019/03/29194.4000.0093.3011,9010.05%
2019/03/28195.30197.0094.7001,8710.00%
2019/03/275100.304100.4398.2011,8410.05%
2019/03/2616100.2516102.39103.5001,7950.00%
2019/03/25295.00194.9095.2011,7020.06%
2019/03/2100.00193.9094.20-11,665-0.06%
2019/03/20292.60193.3093.0011,6400.06%
2019/03/1900.00394.4096.70-31,598-0.19%
2019/03/15295.25995.6995.50-71,589-0.44%
2019/03/141396.083194.8495.70-181,552-1.16%
2019/03/1300.00193.4093.30-11,491-0.07%
2019/03/12291.10391.6793.20-11,445-0.07%
2019/03/111191.86691.7291.3051,3940.36%
2019/03/081488.66689.5289.4081,3020.61%
2019/03/071084.201483.3984.80-41,162-0.34%
2019/02/2700.00577.7277.50-51,019-0.49%
2019/02/26578.1000.0077.6051,0140.49%
2019/02/2200.00278.8578.10-21,014-0.20%
2019/02/21279.10279.9079.1001,0160.00%
2019/02/20380.27180.4079.2021,0220.20%
2019/02/19278.45379.3078.90-1990-0.10%
2019/02/18278.20478.8078.70-2990-0.20%
2019/02/15679.1800.0078.5069870.61%
2019/02/1300.00178.2078.80-1930-0.11%
2019/02/1200.00277.1578.50-2920-0.22%
2019/02/1100.00274.8074.80-2888-0.22%
2019/01/30274.1000.0074.0028920.22%
2019/01/25175.6000.0075.8019020.11%
2019/01/2300.00675.4775.80-6900-0.67%
2019/01/221076.52477.4075.4069080.66%
2019/01/21375.50275.7076.1019070.11%
2019/01/16275.7000.0074.9029430.21%
2019/01/14275.4500.0076.1029630.21%
2019/01/1100.00176.1075.20-1965-0.10%
2019/01/10376.5300.0076.0039610.31%
2019/01/0900.00577.6077.80-5942-0.53%
2019/01/08579.7000.0078.1059300.54%
2019/01/0700.00577.5077.30-5891-0.56%
2019/01/04573.30375.5776.5028540.23%
2018/12/2700.00170.3070.80-1861-0.12%
2018/12/25168.2000.0068.4019180.11%
2018/12/20169.50268.7068.60-11,052-0.10%
2018/12/19170.8000.0070.2011,0950.09%
2018/12/10373.0300.0073.6031,3140.23%
2018/12/05171.7000.0071.7011,5600.06%
2018/12/0300.00171.7071.60-11,703-0.06%
2018/11/19169.7000.0069.5011,8630.05%
2018/11/0900.00168.2067.90-11,951-0.05%
2018/11/0600.00271.0068.60-21,958-0.10%
2018/10/2500.00178.6078.50-11,930-0.05%
2018/10/23181.20281.5079.00-11,915-0.05%
2018/10/17179.60180.0078.3001,8890.00%
2018/10/16179.4000.0079.0011,8910.05%
2018/10/11175.50175.3077.5001,8890.00%
2018/10/081081.2000.0081.50101,8990.53%
2018/10/05181.5000.0083.4011,9150.05%
2018/10/02486.45285.6582.2021,8380.11%
2018/10/0100.00285.9085.80-21,746-0.11%
2018/09/27284.3000.0084.4021,7230.12%
2018/09/26184.80182.0083.8001,7060.00%
2018/09/25689.831089.7587.60-41,662-0.24%
2018/09/21588.0000.0088.3051,6400.30%
2018/09/17487.10586.6686.30-11,497-0.07%
2018/09/1400.002.188.0288.80-2.11,469-0.14%
2018/09/12189.20388.9786.30-21,386-0.14%
2018/09/11287.051.187.3987.600.91,2880.07%
2018/09/071082.251080.5079.3001,0400.00%
2018/09/0600.00179.0080.00-1961-0.10%
2018/09/05177.701079.3479.80-9915-0.98%
2018/09/041076.3700.0077.70108361.20%
2018/08/3000.00171.0071.20-1730-0.14%
2018/08/16173.3000.0073.4016270.16%
2018/08/1400.00171.0071.90-1602-0.17%
2018/08/13167.5000.0069.1015810.17%
2018/08/0600.00272.1572.50-2532-0.38%
2018/07/1600.00171.7071.30-1386-0.26%
2018/07/1300.00269.5069.90-2348-0.57%
2018/06/2900.00466.1066.90-4298-1.34%
2018/06/2800.00366.5065.90-3296-1.01%
2018/06/2200.00366.6066.00-3319-0.94%
2018/05/2400.00164.6063.80-1357-0.28%
2018/05/23163.5000.0064.2013490.29%
2018/05/16261.7000.0061.7023360.59%
2018/04/2000.000.163.0063.10-0.1337-0.03%
2018/04/17161.0000.0061.3013350.30%
2018/04/1300.00163.0062.60-1336-0.30%
2018/04/12163.4000.0063.0013380.30%
2018/03/26167.50167.3067.0002420.00%
2018/03/2100.00164.5063.40-1182-0.55%
2018/03/14162.2000.0062.5011620.61%
2018/03/13161.9000.0062.0011570.64%
2018/03/1200.00462.6062.20-4155-2.56%
2018/02/09156.00155.4056.1001530.00%
2018/02/08157.2000.0057.2011490.67%
2018/02/0500.00159.4059.40-1143-0.69%
2018/02/01160.3000.0060.1011440.69%
水星生醫*攜手旭富製藥 簽訂MTA開發抗癲癇藥物Anue鉅亨-2024/04/15
旭富新產能到位本季營運看增 觀音新廠產能再增5成Anue鉅亨-2023/10/03
星國阿茲海默三期順利解盲 旭富獨供原料藥營運吞補丸Anue鉅亨-2022/11/23
旭富 相關文章